149 related articles for article (PubMed ID: 21057241)
1. A comparison of antipsychotic drug-defined daily doses versus chlorpromazine equivalent doses in patients with or without extrapyramidal motor symptoms.
Barr AM; Honer WG; Johnson JL; Wu TK; Procyshyn RM
J Clin Psychopharmacol; 2010 Dec; 30(6):741-3. PubMed ID: 21057241
[No Abstract] [Full Text] [Related]
2. Interpatient variations in antipsychotic therapy.
McIntyre IM; Gershon S
J Clin Psychiatry; 1985 May; 46(5 Pt 2):3-5. PubMed ID: 2859279
[TBL] [Abstract][Full Text] [Related]
3. Chlorpromazine equivalents versus defined daily doses: how to compare antipsychotic drug doses?
Rijcken CA; Monster TB; Brouwers JR; de Jong-van den Berg LT
J Clin Psychopharmacol; 2003 Dec; 23(6):657-9. PubMed ID: 14624195
[TBL] [Abstract][Full Text] [Related]
4. Adverse reactions to chlorpromazine in psychiatric patients.
Swett C
Dis Nerv Syst; 1974 Nov; 35(11):509-11. PubMed ID: 17896459
[TBL] [Abstract][Full Text] [Related]
5. Extrapyramidal side effects: a historical perspective.
Rifkin A
J Clin Psychiatry; 1987 Sep; 48 Suppl():3-6. PubMed ID: 2887555
[TBL] [Abstract][Full Text] [Related]
6. Evolutionary origin of extrapyramidal disorders in drug-treated mental patients, its significance, and the role of neuromelanin.
Forrest FM
Adv Biochem Psychopharmacol; 1974; 9(0):255-68. PubMed ID: 4151764
[No Abstract] [Full Text] [Related]
7. Blood levels of neuroleptics: state of the art.
Simpson GM; Yadalam K
J Clin Psychiatry; 1985 May; 46(5 Pt 2):22-8. PubMed ID: 2859277
[TBL] [Abstract][Full Text] [Related]
8. [Neuroleptics and the extrapyramidal system].
Haase HJ
Arzneimittelforschung; 1978; 28(9):1536-7. PubMed ID: 38814
[No Abstract] [Full Text] [Related]
9. Recognition and management of acute neuroleptic-induced extrapyramidal motor and mental syndromes.
Dose M
Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():3-13. PubMed ID: 11072761
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia.
Dufresne RL; Wagner RL
J Clin Psychiatry; 1988 Nov; 49(11):435-8. PubMed ID: 2903141
[TBL] [Abstract][Full Text] [Related]
11. An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms.
Timdahl K; Carlsson A; Stening G
Hum Psychopharmacol; 2007 Jul; 22(5):315-25. PubMed ID: 17542047
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
Suh GH; Greenspan AJ; Choi SK
Int J Geriatr Psychiatry; 2007 May; 22(5):494-5. PubMed ID: 17471597
[No Abstract] [Full Text] [Related]
13. [Extrapyramidal complications during treatment with chlorpromazine and reserpine: clinical and electromyographic study].
Delay J; Deniker P; Bourguignon A; Lempérière T
Vertex; 2005; 16(64):469-72. PubMed ID: 16314902
[No Abstract] [Full Text] [Related]
14. Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy.
Hriso E; Kuhn T; Masdeu JC; Grundman M
Am J Psychiatry; 1991 Nov; 148(11):1558-61. PubMed ID: 1681751
[TBL] [Abstract][Full Text] [Related]
15. Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study.
Sramek JJ; Simpson GM; Morrison RL; Heiser JF
J Clin Psychiatry; 1986 Jun; 47(6):305-9. PubMed ID: 2872206
[TBL] [Abstract][Full Text] [Related]
16. Increased hexosaminidase activity in antipsychotic-induced extrapyramidal side effects: possible association with higher occurrence in bipolar disorder patients.
Tunca Z; Resmi H; Ozkara HA; Ciliv G; Celtikci B; Alptekin K; Ozerdem A; Akdede BK; Baykara B; Birsoy B; Ergor G
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1214-20. PubMed ID: 18436361
[TBL] [Abstract][Full Text] [Related]
17. [Extrapyramidal movement disorders arising during treatment of psychoses with drugs].
Vatsek Ia
Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(3):453-7. PubMed ID: 4940
[No Abstract] [Full Text] [Related]
18. Antipsychotic medication: clinical guidelines for maintenance therapy.
Johnson DA
J Clin Psychiatry; 1985 May; 46(5 Pt 2):6-15. PubMed ID: 2859281
[TBL] [Abstract][Full Text] [Related]
19. The risks and benefits of clozapine versus chlorpromazine.
Claghorn J; Honigfeld G; Abuzzahab FS; Wang R; Steinbook R; Tuason V; Klerman G
J Clin Psychopharmacol; 1987 Dec; 7(6):377-84. PubMed ID: 3323261
[TBL] [Abstract][Full Text] [Related]
20. Lack of association between antipsychotic-induced extrapyramidal symptoms and polymorphisms in dopamine metabolism and transport genes.
Gassó P; Mas S; Crescenti A; Alvarez S; Parramon G; Garcia-Rizo C; Parellada E; Bernardo M; Lafuente A
Psychiatry Res; 2010 Jan; 175(1-2):173-5. PubMed ID: 19892410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
